Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 5560, 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38448683

ABSTRACT

Deformable attention only focuses on a small group of key sample-points around the reference point and make itself be able to capture dynamically the local features of input feature map without considering the size of the feature map. Its introduction into point cloud registration will be quicker and easier to extract local geometric features from point cloud than attention. Therefore, we propose a point cloud registration method based on Spatial Deformable Transformer (SDT). SDT consists of a deformable self-attention module and a cross-attention module where the deformable self-attention module is used to enhance local geometric feature representation and the cross-attention module is employed to enhance feature discriminative capability of spatial correspondences. The experimental results show that compared to state-of-the-art registration methods, SDT has a better matching recall, inlier ratio, and registration recall on 3DMatch and 3DLoMatch scene, and has a better generalization ability and time efficiency on ModelNet40 and ModelLoNet40 scene.

2.
Front Aging Neurosci ; 12: 188, 2020.
Article in English | MEDLINE | ID: mdl-32733231

ABSTRACT

Current researches on default mode network (DMN) in normal elderly have mainly focused on finding some dysfunctional areas with decreased or increased connectivity. The global network dynamics of apolipoprotein E (APOE) e4 allele group is rarely studied. In our previous brain network study, we have demonstrated the advantage of persistent homology. It can distinguish robust and noisy topological features over multiscale nested networks, and the derived properties are more stable. In this study, for the first time we applied persistent homology to analyze APOE-related effects on whole-brain functional network. In our experiments, the risk allele group exhibited lower network radius and modularity in whole brain DMN based on graph theory, suggesting the abnormal organization structure. Moreover, two suggested measures from persistent homology detected significant differences between groups within the left hemisphere and in the whole brain in two datasets. They were more statistically sensitive to APOE genotypic differences than standard graph-based measures. In summary, we provide evidence that the e4 genotype leads to distinct DMN functional alterations in the early phases of Alzheimer's disease using persistent homology approach. Our study offers a novel insight to explore potential biomarkers in healthy elderly populations carrying APOE e4 allele.

3.
Molecules ; 25(11)2020 May 27.
Article in English | MEDLINE | ID: mdl-32471036

ABSTRACT

Despite the severe social burden caused by Alzheimer's disease (AD), no drug than can change the disease progression has been identified yet. The structural brain network research provides an opportunity to understand physiological deterioration caused by AD and its precursor, mild cognitive impairment (MCI). Recently, persistent homology has been used to study brain network dynamics and characterize the global network organization. However, it is unclear how these parameters reflect changes in structural brain networks of patients with AD or MCI. In this study, our previously proposed persistent features and various traditional graph-theoretical measures are used to quantify the topological property of white matter (WM) network in 150 subjects with diffusion tensor imaging (DTI). We found significant differences in these measures among AD, MCI, and normal controls (NC) under different brain parcellation schemes. The decreased network integration and increased network segregation are presented in AD and MCI. Moreover, the persistent homology-based measures demonstrated stronger statistical capability and robustness than traditional graph-theoretic measures, suggesting that they represent a more sensitive approach to detect altered brain structures and to better understand AD symptomology at the network level. These findings contribute to an increased understanding of structural connectome in AD and provide a novel approach to potentially track the progression of AD.


Subject(s)
Alzheimer Disease/diagnostic imaging , Brain/diagnostic imaging , White Matter/diagnostic imaging , Aged , Aged, 80 and over , Cognitive Dysfunction/physiopathology , Connectome/methods , Diffusion Tensor Imaging , Female , Humans , Male , Middle Aged
4.
Molecules ; 24(12)2019 Jun 21.
Article in English | MEDLINE | ID: mdl-31234358

ABSTRACT

Recent research of persistent homology in algebraic topology has shown that the altered network organization of human brain provides a promising indicator of many neuropsychiatric disorders and neurodegenerative diseases. However, the current slope-based approach may not accurately characterize changes of persistent features over graph filtration because such curves are not strictly linear. Moreover, our previous integrated persistent feature (IPF) works well on an rs-fMRI cohort while it has not yet been studied on metabolic brain networks. To address these issues, we propose a novel univariate network measurement, kernel-based IPF (KBI), based on the prior IPF, to quantify the difference between IPF curves. In our experiments, we apply the KBI index to study fluorodeoxyglucose positron emission tomography (FDG-PET) imaging data from 140 subjects with Alzheimer's disease (AD), 280 subjects with mild cognitive impairment (MCI), and 280 healthy normal controls (NC). The results show the disruption of network integration in the progress of AD. Compared to previous persistent homology-based measures, as well as other standard graph-based measures that characterize small-world organization and modular structure, our proposed network index KBI possesses more significant group difference and better classification performance, suggesting that it may be used as an effective preclinical AD imaging biomarker.


Subject(s)
Alzheimer Disease/metabolism , Brain/metabolism , Cognitive Dysfunction/metabolism , Metabolic Networks and Pathways , Aged , Alzheimer Disease/diagnosis , Alzheimer Disease/pathology , Brain/diagnostic imaging , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/pathology , Female , Fluorodeoxyglucose F18/administration & dosage , Humans , Magnetic Resonance Imaging , Male , Positron-Emission Tomography
SELECTION OF CITATIONS
SEARCH DETAIL
...